SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Schedule of Revenue by Payor Class

Revenue by payor class as a percentage of total net service revenue is as follows:

	For the Three- Month Periods Ended March 31
	2019		2018
Home Health:
Medicare	46	%	51	%
Non-Medicare - Episodic-based	9	%	8	%
Non-Medicare - Non-episodic based	12	%	12	%
Hospice:
Medicare	28	%	23	%
Non-Medicare	1	%	1	%
Personal Care	4	%	5	%
	100	%	100	%

Schedule of Fair Value of Financial Instruments

The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):

	Fair Value at Reporting Date Using
Financial Instrument	Carrying Value as of March 31, 2019		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	311.2	$	—	$	310.0	$	—

Schedule of Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):

	For the Three- Month Periods Ended March 31,
	2019	2018
Weighted average number of shares outstanding - basic	32,001	33,971
Effect of dilutive securities:
Stock options	559	334
Non-vested stock and stock units	333	287
Weighted average number of shares outstanding - diluted	32,893	34,592
Anti-dilutive securities	148	182